Emerging Mumps Infection.
暂无分享,去创建一个
[1] E. Belongia,et al. Mumps Antibody Response in Young Adults After a Third Dose of Measles-Mumps-Rubella Vaccine , 2014, Open forum infectious diseases.
[2] R. Bremel,et al. Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes? , 2013, Human vaccines & immunotherapeutics.
[3] A. Oberg,et al. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. , 2013, Seminars in immunology.
[4] W. Bellini,et al. Epidemiology of a Mumps Outbreak in a Highly Vaccinated Island Population and Use of a Third Dose of Measles–Mumps–Rubella Vaccine for Outbreak Control—Guam 2009 to 2010 , 2013, The Pediatric infectious disease journal.
[5] W. Bellini,et al. Comparison of the Sensitivity of Laboratory Diagnostic Methods from a Well-Characterized Outbreak of Mumps in New York City in 2009 , 2013, Clinical and Vaccine Immunology.
[6] I. Ogbuanu,et al. Impact of a Third Dose of Measles-Mumps-Rubella Vaccine on a Mumps Outbreak , 2012, Pediatrics.
[7] M. Paunio,et al. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. , 2012, The Journal of infectious diseases.
[8] S. Rubin,et al. Recent Mumps Outbreaks in Vaccinated Populations: No Evidence of Immune Escape , 2011, Journal of Virology.
[9] W. Bellini,et al. Enzyme-Linked Immunospot Assay Detection of Mumps-Specific Antibody-Secreting B Cells as an Alternative Method of Laboratory Diagnosis , 2010, Clinical and Vaccine Immunology.
[10] A. Curns,et al. Mumps vaccine performance among university students during a mumps outbreak. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] M. Hilleman,et al. Live, attenuated mumps-virus vaccine. , 1968, The New England journal of medicine.
[12] M. Hilleman,et al. Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. , 1967, The New England journal of medicine.